Quality of life and the impact of drug toxicities in a South African community-based antiretroviral programme

Journal of the International AIDS Society

Volumn 12, Issue 1, 2009, Pages

  Pitt, Jennifer ^a   Myer, Landon ^b,c   Wood, Robin ^a  

^a Institute of Infectious Disease and Molecular Medicine   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE;

ADULT; ADVERSE DRUG REACTION; ALLERGIC REACTION; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMMUNITY CARE; CONTROLLED STUDY; DEMOGRAPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLACTATEMIA; HYPERTRANSAMINASEMIA; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; SOUTH AFRICA; SOUTH AFRICAN; VIRUS LOAD;

EID: 84942292865     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-12-5     Document Type: Article

References (31)

1. UNAIDS: AIDS Epidemic Update WHO Geneva; 2006.
2. Dorrington R, Johnson L, Bradshaw D, Daniel TJ: The demographic impact of HIV/AIDS in South Africa: National and provincial indicators for 2006. Cape Town: Centre for Actuarial Research, South African Medical Research Council and Actuarial Society of South Africa; 2006.
3. United States President's Emergency Plan for AIDS Relief: Partnership to fight HIV/AIDS in South Africa. 2008 [http://www.pep far.gov/countries/southafrica/index.htm]. (Last accessed on 11 March 2009.)
4. Wachtel T, Piette J, Mor V, Stein M, Fleischman J, Carpenter C: Quality of life in persons with human immunodeficiency virus infection: measurement by the medical outcomes study instrument. Annals of Internal Medicine 1992, 116:129-137.
5. Franchi D, Wenzel RP: Measuring health-related quality of life among patients infected with human immunodeficiency virus. Clin Infect Dis 1998, 26:20-26.
6. Wu AW: Quality of life assessment comes of age in the era of highly active antiretroviral therapy. AIDS 2000, 14:1449-1451.
7. Casado A: Measurement of quality of life of HIV individuals: perspectives and future directions. Indian J Med Res 2005, 122:282-284.
8. Clayson DJ, Wild DJ, Quarterman P, Duorat-Lomon I, Kubin M, Coons SJ: A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials. Pharmacoeconomics 2006, 24(8):751-765.
9. Brechtl JR, Breitbart W, Galietta M, Krivo S, Rosenfeld B: The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: impact on medical, palliative care, and quality of life outcomes. Journal of Pain and Symptom Management 2001, 21:41-51.
10. Murri R, Fantoni M, Del Borgo C, Visona R, Barracco A, Zambelli A, Testa L, Orchi N, Tozzi V, Bosco O, Wu AW: Determinants of health-related quality of life in HIV-infected patients. AIDS Care 2003, 15(4):581-590.
11. Burgoyne RW, Rourke SB, Behrens DM, Salit IE: Long-term quality-of-life outcomes among adults living with HIV in the HAART era. AIDS and Behaviour 2004, 8(2):151-163.
12. Carrieri P, Spire B, Duran S, et al.: Health-related quality of life after 1 year of highly active antiretroviral therapy. JAIDS 2003, 32:38-47.
13. Gill CJ, Griffith JL, Jacobson D, Skinner S, Gorbacj SL, Wilson IB: Relationship of HIV viral loads, CD4 counts and HAART use to health-related quality of life. J Acquir Immune Defic Syndr 2002, 30(5):485-492.
14. Liu C, Ostrow D, Detels R, Hu Z, Johnson L, Kingsley L, Jacobson LP: Impacts of HIV infection and HAART use on quality of life. Qual Life Res 2006, 15:941-949.
15. Van Leth F, Conway B, Laplume H, Martin D, Fisher M, Jelaska A, Wit F, Lange JMA: Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine and/or efavirenz. Antiviral Ther 2004, 9:721-728.
16. Wouters E, Meulemans H, Van Rensburg HCJ, Heunis JC, Mortelmans D: Short-term physical and emotional health outcomes of public sector ART in the Free State province of South Africa. Qual Life Res 2007, 16:1461-1471.
17. Louwagie GM, Bachman MO, Meyer K, Booysen FR, Fairall LR, Heunis C: Highly active antiretroviral treatment and health related quality of life in South African adults with human immunodeficiency virus infection: a cross-sectional analytical study. BMC Public Health 2007, 7:244-254.
18. Stangl AL, Wamai N, Mermin J, Awor AC, Bunnell RE: Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda. AIDS Care 2007, 19(5):626-636.
19. Jelsma J, Maclean E, Hughes J, Tinise X, Darder M: An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS Care 2005, 17(5):579-588.
20. Wu AW, Mathews WC, Brysk LT, Atkinson JH, Grant I, Abramson I, Kennedy CJ, McCutchan JA, Spector SA, Richman DD: Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. J Acquir Immune Defic Syndr 1990, 3:683-689.
21. Boulle A, Orrell C, Kaplan R, Van Cutsem G, McNally M, Hilderbrand K, Myer L, Egger M, Coetzee D, Maartens G, Wood R: Substitutions due to antiretroviral toxicity or contraindication in the first three years of antiretroviral therapy in a large South African cohort. Antiviral Therapy 2007, 12:753-760.
22. National Department of Health, South Africa: National Antiretroviral Treatment Guidelines. Pretoria 1st edition. 2004.
23. World Health Organisation: Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Executive summary 2000.
24. Ware JE, Sherbourne CD: The MOS 36-Item Short Form Health Survey (SF-36). MedCar 1992, 30(8):473-480.
25. Bing EG, Hays RD, Jacobson LP, Chen B, Gange SJ, Kass NE, Chmiel JS, Zucconi SL: Health-related quality of life among people with HIV disease: results from the multicentre AIDS cohort study. Qual Life Res 2000, 9:55-63.
26. Call SA, Klapow JC, Stewart KE, Westfall AO, Mallinger AP, DeMasi RA, Centor R, Saag MS: Health-related quality of life and virologic outcomes in an HIV clinic. Qual Life Res 2001, 9:977-985.
27. Bastardo YM, Kimberlin CL: Relationship between quality of life, social support and disease-related factors in HIV-infected persons in Venezuela. AIDS Care 2000, 12(5):673-684.
28. O'Keefe EA, Wood R: The impact of human immunodeficiency virus (HIV) infection on quality of life in a multiracial South African population. Qual Life Res 1996, 5:275-280.
29. Lawn SD, Myer L, Orrell C, Bekker LG, Wood R: Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 2005, 19(18):2141-2148.
30. Lawn SD, Myer L, Harling G, Orrell C, Bekker LG, Wood R: Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis 2006, 43(6):770-776.
31. Liu C, Johnson L, Ostrow D, Silvestre A, Visscher B, Jacobson LP: Predictors of quality of life in the HAART era among HIV-infected men. J Acquir Immune Defic Syndr 2006, 42(4):470-477.